Özet:

Group B streptococci (GBS) is one of the leading couses of infection in newborns, in pregnant women, and in patients with underlying diseases. GBS are sensitive to penicilin, that’s why, penicilin must be the first choice in the treatment. Other antibiotics which GBS are sensitive to are; ampicillin, vancomycin, teicoplanin, first, second and third generation cephalosporins, imipenem and meropenem. Clindamycin and erythromycin resistance rates are 15-20 % and they are increasing worldwide. One hundred thirty one S.agalactiae strains, isolated from the clinical samples of patients applied to Erciyes University Medical Faculty Hospitals between the dates of 30th July 2005 and 4th October 2006, were included to the study. It was determined that all GBS isolates were susceptible to penicillin G, ceftriaxone and vancomycin. Among strains, tetracycline, erythromycin and clindamycin resistance rates were determined as 90 %, 14,5 % and 13 % respectively. In our region there is no resistance problem to penicillin G and ceftriaxone among GBS and they are still the first choice in GBS infections. It was determined that the erythromycin resistance doubled in comparison with the past studies and these kinds of antibiotics should not be preferred except for beta-lactam allergy

Anahtar Kelimeler: